• 제목/요약/키워드: Somatotropin

검색결과 76건 처리시간 0.018초

재조합 소성장호르몬의 구조적 특성 (The Structural Characterization of Recombinant Bovine Somatotropin Expressed in Escherichia coli)

  • 김정호;김훈주박은숙김준
    • KSBB Journal
    • /
    • 제9권2호
    • /
    • pp.165-173
    • /
    • 1994
  • 재조합 소성장호르몬을 트립신, S.aureus V8 단백질가수분해효소, CNBr, 그리고 산 가수분해법을 이용하여 단백질 일차구조 분석을 실시하였다. N-말단 분석은 30 잔기까지를 수행하였는데, 대장균 내에서 발현된 소성장호르몬은 E. coli 내 에 존재 하는 methionyl-aminopeptidase에 의해 해독개시인자로 넣어준 N-말단의 Met이 모두 제거된 형태로 나타났으며 아미노산 조성분석 결과 연역된 조성과 유사하게 나타났다. 효소와 화학물질로 절단한 소성장호르몬 조각들을 HPLC로 분리한 후 단백질 서열분석기를 이용하여 아미노산 서열을 분석하였다. 대장균에서 발현된 소성장호르몬은 191개의 아미노산으로 구성된 21,802 Da의 분자량을 갖고 있는 단백질로 나타났다. 여기에서 을 갖고 있는 단백질로 나타났다. 여기에서 얻은 아미노산 서열을 바탕으로 hydropathy plot을 한 결과 N-말단에서는 소수성이 그리고 C-말단에서는 친수성 영역이 나타났다.

  • PDF

비육우에서 이식형 bovine somatotropin 지속성 제형의 blood profile test (Blood profile test of sustained release formula of implantable bovine somatotropin in steers)

  • 김남중
    • 대한수의학회지
    • /
    • 제49권1호
    • /
    • pp.9-15
    • /
    • 2009
  • The present study was carried out to examine the sustained release effect of the implantable bovine somatotropin (SRI-BST) formula. In the blood profile test in steers, the bovine somatotropin concentration in serum by radioimmunoassay showed the peak concentration on the first day after the implantation of the SRI-BST formula, and concentration proceeded for 5 days (p < 0.05). The insulin-like growth factor-1 concentration showed the peak concentration on the seventh day after implantation of the SRIF-BST formula, and concentration proceeded for 10 days (p < 0.05). The glucose showed the peak concentration on the first day after implantation of the SRI-BST formula, and concentration continued for 3 days (p < 0.05). The blood urea nitrogen showed the lowest concentration on the third day after implantation of the SRI-BST formula, and concentration continued for 7 days (p < 0.05). These results proved that the SRIF-BST formula was the sustained release effects in steers.

유전자재조합 Bovine Somatotropin 투여가 우유중의 Bovine Somatotropin 농도에 미치는 영향 (Effect of Recombinant Bovine Somatotropin Administration on Bovine Somatotropin Levels in Cow Milk)

  • 최정은;최명자;진재호;김주호;박종세
    • 한국식품위생안전성학회지
    • /
    • 제10권2호
    • /
    • pp.61-64
    • /
    • 1995
  • The present study was conducted to examine the effect of recombinant bovine somatotrpin(${\gamma}$BST), which was administered to cow to promote milk production, on bST levels in milk. Fourteen cows were divided cows were divided into two groups: 1) control cows received neither ${\gamma}$bST nor vehicle, 2) treated cows were administered twice at two-week interval with 500 mg ${\gamma}$bST each cow byj after lst injection. Milk samples were taken on day 0 (prior to injection), day 7 (7 days after lst injection), day 21 (7 days after 2nd injection) and day 35 (21 days after 2nd injection). Milk bST concentration was measured by the radioimmunoassay method. There was no statistical difference(p<0.05) in milk bST levels between two groups showing bST levels in the range of 1.8 ng/m/ to 3.1 ng/m/. That is, ${\gamma}$bST administration did not increase bST levels in milk.

  • PDF

Somatotropin 이식 제형 개발과 지속적 방출 효과 (Development and sustained release effect of implantable formula of somatotropin)

  • 김남중
    • 대한수의학회지
    • /
    • 제48권1호
    • /
    • pp.27-32
    • /
    • 2008
  • The present study was carried out to develop a sustained release implantable formula of bovine somatotropin (SRIF-BST) and to examine its sustained release effect. The SRIF-BST was produced by coating a solid pellet, which was comprised of BST and an excipient, made of a biodegradable polymer and poloxamer, which are capable of regulating the rate of BST release. The coated membrane of SRIFBST was observed with a field emission scanning electron microscope. The thickness of the coated membrane was approximately $1{\mu}m$, and the pore sizes of the coated membrane surface were below $10{\mu}m$. In dissolution test, the release duration of the SRIF-BST maintained for 10 days, whereas the release duration of the control BST formula maintained for 3 days. In weight gain assay and tibia test of hypophysectomized rats, the release duration of the SRIF-BST treated group was 12 days and the net weight gain was 53.16 g, also the tibia length and strength of the SRIF-BST treated group was increased 10.5% and 23.1% compared with those of the control group, respectively.

비육우, 젖소 및 비육돈에서 이식형 소마토트로핀 지속성 제형의 유효성 시험 연구 (Efficacy test of sustained-release somatotropin by implantation in steer, cow and barrow)

  • 김남중
    • 대한수의학회지
    • /
    • 제51권1호
    • /
    • pp.1-6
    • /
    • 2011
  • Sixteen steers were used to investigate the efficacy of the sustained-release implant of bovine somatotropin (bST) in improving growth and feed:gain ratio during 12 weeks. Administration of the 400 mg bST implant resulted in a 16.1% increase in growth rate, and this increase was significant (p<.05). The use of the sustained-release implant did not alter (p>.05) feed intake and feed:gain ratio. Thirty-four cows were used to investigate the efficacy of the sustained-release implant of bST in milk production during 4 weeks. Administration of the 200 mg bST implant resulted in an 8.7% increase in milk production, and this increase was significant (p<.05). Twenty-four barrows were used to investigate the efficacy of the sustained-release implant of porcine somatotropin (pST) in improving growth, feed:gain ratio and backfat thickness during 6 weeks. Administration of the 120 mg pST implant resulted in a 11.4% increase in feed:gain ratio and a 60% decrease in backfat thickness, and these results were significant (p<.05). But the use of the sustained-release implant did not alter (p>.05) growth rate and feed intake.

AN INVESTIGATION OF IMMUNIZATION AGAINST SOMATOSTATIN BY MEASURING ANTIBODY TITRES, SOMATOSTATIN AND SOMATOTROPIN PROFILES IN GILTS

  • Du, Z.L.;Hacker, R.R.
    • Asian-Australasian Journal of Animal Sciences
    • /
    • 제6권2호
    • /
    • pp.211-218
    • /
    • 1993
  • The effect of active immunization against porcine somatostatin (SRIF-14) on somatostation and somatotropin secretion profile in 18 gilts was investigated. Gilts were assigned to the following treatments: control (sham injection, n = 6); bovine serum albumin (BSA) (injection of BSA with bacterial protein adjuvant, n = 6); SRIF (injection of BSA-SRIF-14 conjugate with bacterial protein adjuvant n = 6). Serum SRIF and pST were assayed from the blood samples taken on day 7 after the last immunization injection. Anti-SRIF antibody titres were assayed in weekly samples two weeks after the initial immunization to one week after the last immunization. Results revealed that the immunization protocol used in the present investigation failed to produce antibodies capable of neutralizing endogenous somatostatin. In addition, the porcine somatotropin assay revealed no significant differences in baseline pST concentration, mean peak amplitude and number of peaks during a 24 h secretory period among SRIF, BSA and control treatment. There were also no differences in SRIF baseline concentration, peak amplitude, and number of peaks during a 24 h secretory period among any of the three treatments. Circulating concentrations of pST and pSRIF were highly correlated (r = -0.09). Furthermore, anti-SRIF antibody titre was not detected in the serum of the gilts actively immunized against SRIF. These data, collectively, suggest that the protocol employed in the present investigation for active immunization against SRIF is not an effective method for changing SRIF and pST secretion profiles of the gilt and thus to enhance performance.

EFFECT OF RECOMBINANT BOVINE SOMATOTROPIN ON MILK PRODUCTION AND MILK COMPOSITION IN DAIRY COWS

  • Myung, K.H.
    • Asian-Australasian Journal of Animal Sciences
    • /
    • 제3권3호
    • /
    • pp.247-252
    • /
    • 1990
  • Nine Holstein cows in mid lactation period were utilized to examine the effect of recombinant bovine somatotropin (BST) of tow companies (Company A, Company B) on milk production and milk composition under the feeding conditions of Korea. Treatments were 0 (Control), 25 mg BST/day from company A (BST A) and 25 mg BST/day from company B (BST B) injected subcutaneously, once daily beginning at $200{\pm}20$ days postpartum and continuing for 28 days. Cows were fed ad libitum a total mixed diet throughout the experimental period. BST treatments increased average 4% fat corrected milk yields and milk energy output over the 28-day treatment period. However, no differences were observed in dry matter intake, gross efficiency, energy intake and percent milk energy. Although there was a tendency for increased milk fat percent, there were no differences in milk composition and yields of major milk components except for milk fat yield with BST injection. Somatic cells of all groups were also characteristic of a well managed herd. Neither mean body condition score nor body weight was significantly (p <0.05) changed before and during BST treatment. BST concentration in milk remained in the range of control animals throughout the experimental period of BST treatment. Results indicate that short-term injection of recombinant bovine somatotropin from two companies to lactating dairy cow resulted in similar increased in milk yield without alteration of major milk components or feed intake.